Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,396 | -47,511 | -10,087 | -113,575 | -82,880 |
| Depreciation Amortization | 6,178 | 4,235 | 2,135 | 7,384 | 5,279 |
| Accounts receivable | -6,409 | -4,573 | -60,211 | -11,103 | -10,080 |
| Accounts payable and accrued liabilities | -11,628 | -5,613 | 8,194 | -7,008 | -11,388 |
| Other Working Capital | 25,136 | 29,714 | -26,317 | -5,142 | -22,183 |
| Other Operating Activity | 71,929 | 51,865 | 70,156 | 105,339 | 90,100 |
| Operating Cash Flow | $20,810 | $28,117 | $-16,130 | $-24,105 | $-31,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -609 | -550 |
| Purchase Of Investment | -127,072 | -127,974 | -86,715 | -107,502 | -71,112 |
| Sale Of Investment | 132,667 | 94,597 | 42,132 | 50,488 | 11,457 |
| Investing Cash Flow | $5,595 | $-33,377 | $-44,583 | $-57,623 | $-60,205 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | 25,000 | N/A | 105,000 | 75,000 |
| Debt Repayment | -80,000 | -80,000 | N/A | N/A | 0 |
| Common Stock Issued | 1,352 | 1,276 | 1,082 | 7,652 | 7,151 |
| Other Financing Activity | -13,418 | -13,418 | 0 | -4,201 | -4,192 |
| Financing Cash Flow | $-67,066 | $-67,142 | $1,082 | $108,451 | $77,959 |
| Beginning Cash Position | 112,738 | 112,738 | 112,738 | 86,015 | 86,015 |
| End Cash Position | 72,077 | 40,336 | 53,107 | 112,738 | 72,617 |
| Net Cash Flow | $-40,661 | $-72,402 | $-59,631 | $26,723 | $-13,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,810 | 28,117 | -16,130 | -24,105 | -31,152 |
| Capital Expenditure | 0 | N/A | N/A | -609 | -550 |
| Free Cash Flow | 20,810 | 28,117 | -16,130 | -24,714 | -31,702 |